Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies

Results: 1652 (Showing 1401 to 1420) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Inflammation and Sex Hormones in Relation to Prostate Cancer Risk Ann Hsing NCI, DCEG, HREB PLCO Oct 15, 2007 2007-0046
Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Jul 27, 2007 2005-0015
Genetic analysis for carcinogen metabolism-related lung cancer risk among heavy smokers in the PLCO Trial SNP analysis Timothy Church University of Minnesota PLCO Jul 10, 2007 2007-0009
Helicobacter pylori seropositivity as a Risk Factor for Pancreatic Cancer Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Jul 10, 2007 2007-0001
Common Genetic Variation and the Risk of Multiple Myeloma Sonja Berndt NCI, DCEG, OEEB PLCO Jul 10, 2007 2007-0032
A Whole Genome Association Study (WGAS) of Lung Cancer and Smoking Neil Caporaso NCI, DCEG, GEB PLCO Jun 19, 2007 2007-0004
Genomic Variation and Risk of Breast, Prostate, Lung and Colorectal Cancers: a Kin-Cohort Study within CGEMS Mark Purdue NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0033
Predictors of compliance with baseline sigmoidoscopy in the PLCO screening trial Paul Doria-Rose NCI, DCP PLCO Jun 12, 2007 2007-0028
Impact of control composition on genetic association studies Sholom Wacholder NCI, DCEG, BB PLCO Jun 12, 2007 2007-0035
Genetic Polymorphisms of Selenoproteins and Prostate Cancer Richard Hayes NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0036
Energy Balance, Anthropometry, Hormone Therapy and Risk of Breast Cancer. Regina Ziegler NCI, DCEG, EBP PLCO Jun 12, 2007 2007-0039
Circadian Genes and Serum Levels of Sex Hormones and their Joint Effects on Prostate Cancer Risk Ann Hsing NCI, DCEG, HREB PLCO Jun 12, 2007 2007-0034
CDKAL1 and Prostate Cancer Richard Hayes NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0037
Effect of Baseline Comorbidities on Cancer Screening Trial Adherence among Older African American Men Lois Lamerato Henry Ford Health System PLCO Jun 12, 2007 2007-0040
Polyunsatruated Fat Intake and Prostate Cancer Daniel Koralek University of North Carolina at Chapel Hill - Department of Epidemiology, CB #7435 PLCO Jun 12, 2007 2007-0017
Genetic Determinants of Height and BMI in the PLCO Trial and Collaborating Studies Sonja Berndt NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0038
Xenobiotic Metabolizing Gene Variants, Dietary Meat Mutagen Intake and Risk of Prostate Cancer Stella Koutros NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0029
Polymorphisms in DNA repair genes and the risk of colorectal cancer Sonja Berndt NCI, DCEG, OEEB PLCO May 22, 2007 2007-0012
How does vitamin E supplementation protect against clinically relevant prostate cancer in smokers? A molecular epidemiologic study in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screeni Demetrius Albanes NCI, DCEG, NEB PLCO May 7, 2007 2007-0007
Early Detection of Ovarian Cancer Using Proteomic Analysis of Pre-diagnostic Serum Samples Collected in the PLCO Trial Lee Moore NCI, DCEG, OEEB PLCO May 1, 2007 2006-0300